N. Sertac Kip
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
N. Sertac Kip has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Amanda I. Phipps
Department of Epidemiology, University of Washington, Seattle, USA
1 shared publication - Camila Lopes-Ramos
Harvard T.H. Chan School of Public Health, Boston, MA 02115
1 shared publication - Catherine J. Wu
Dana-Farber Cancer Institute
1 shared publication - Christine B. Ambrosone
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, USA
1 shared publication - Hugo J. W. L. Aerts
Mass General Brigham | Harvard Medical School
1 shared publication - Jeffrey Allen Golden
Department of Pathology, Cedars–Sinai Medical Center, Los Angeles, CA, USA
1 shared publication
Latest Publications
- 8 May 2019
- Published by Springer Nature in Cancer Causes & Control
- Vol. 30 (8) , 799-811
Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting
An important premise of epidemiology is that individuals with the same disease share similar underlying etiologies and clinical outcomes. In the past few decades, our knowledge of disease pathogenesis has improved, and disease classification systems have evolved to the point where no complex disease processes are considered homogenous. As a result, pathology and epidemiology have been integrated into the single, unified field of molecular pathological epidemiology (MPE). Advancing integrative molecular and population-level health sciences and addressing the unique research challenges specific to the field of MPE necessitates assembling experts in diverse fields, including epidemiology, pathology, biostatistics, computational biology, bioinformatics, genomics, immunology, and nutritional and environmental sciences. Integrating these seemingly divergent fields can lead to a greater understanding of pathogenic processes. The International MPE Meeting Series fosters discussion that addresses the specific research questions and challenges in this emerging field. The purpose of the meeting series is to: discuss novel methods to integrate pathology and epidemiology; discuss studies that provide pathogenic insights into population impact; and educate next-generation scientists. Herein, we share the proceedings of the Fourth International MPE Meeting, held in Boston, MA, USA, on 30 May–1 June, 2018. Major themes of this meeting included ‘integrated genetic and molecular pathologic epidemiology’, ‘immunology-MPE’, and ‘novel disease phenotyping’. The key priority areas for future research identified by meeting attendees included integration of tumor immunology and cancer disparities into epidemiologic studies, further collaboration between computational and population-level scientists to gain new insight on exposure-disease associations, and future pooling projects of studies with comparable data.
- 8 May 2019
- Published by Springer Nature in Cancer Causes & Control
- Vol. 30 (8) , 799-811
Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting
An important premise of epidemiology is that individuals with the same disease share similar underlying etiologies and clinical outcomes. In the past few decades, our knowledge of disease pathogenesis has improved, and disease classification systems have evolved to the point where no complex disease processes are considered homogenous. As a result, pathology and epidemiology have been integrated into the single, unified field of molecular pathological epidemiology (MPE). Advancing integrative molecular and population-level health sciences and addressing the unique research challenges specific to the field of MPE necessitates assembling experts in diverse fields, including epidemiology, pathology, biostatistics, computational biology, bioinformatics, genomics, immunology, and nutritional and environmental sciences. Integrating these seemingly divergent fields can lead to a greater understanding of pathogenic processes. The International MPE Meeting Series fosters discussion that addresses the specific research questions and challenges in this emerging field. The purpose of the meeting series is to: discuss novel methods to integrate pathology and epidemiology; discuss studies that provide pathogenic insights into population impact; and educate next-generation scientists. Herein, we share the proceedings of the Fourth International MPE Meeting, held in Boston, MA, USA, on 30 May–1 June, 2018. Major themes of this meeting included ‘integrated genetic and molecular pathologic epidemiology’, ‘immunology-MPE’, and ‘novel disease phenotyping’. The key priority areas for future research identified by meeting attendees included integration of tumor immunology and cancer disparities into epidemiologic studies, further collaboration between computational and population-level scientists to gain new insight on exposure-disease associations, and future pooling projects of studies with comparable data.